It is a solid first step if you are new to GLP-1 therapy and want a proven, steady approach
Early, in-depth review article that evaluates the similarities and differences between short-acting and long-acting GLP-1R agonists in terms of glucose-lowering efficacy and adverse effects, and discusses the possibilities for utilizing these agents for individualized treatment of T2DM
I was crazy about it for the first probably year, year and a half
However, in baby teeth, these lesions could potentially be converted to a manageable condition without the need to fill the cavity
exenatide use was also associated with better global longitudinal strain (18.4 0.4% versus 17.1 0.3%
Of course, these benefits must be balanced against side effects